newsfilter
← Latest News
PR Newswire·

AMYRIS REPORTS Q1 2023 REVENUE

EMERYVILLE, Calif., April 24, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its